Anika Therapeutics | ANIK - Laba Operasional





Laba Operasional Perubahan Tanggal
Abbott USD 2.13B 281M 2026-06
Agenus USD 15.05M 656K 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
MacroGenics USD -33.44M 21.34M 2026-03
Merit Medical Systems USD 60.4M 16.25M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 2.38B 449M 2026-06
Smith & Nephew USD 505M 65M 2026-06
Stryker USD 1.79B 687M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Xencor USD -36.6M 41.26M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06